Journal of Clinical Pathology 2006;59:396-402
ORIGINAL ARTICLE
Enumeration and immunohistochemical characterisation of bone marrow basophils in myeloproliferative disorders using the basophil specific monoclonal antibody 2D7
1 Department of Internal Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Austria
2 Department of Clinical Pathology, Medical University of Vienna
3 Department of Internal Medicine, Division of Rheumatology, Allergy and Immunology, Virginia Commonwealth University, Richmond, Virginia, USA
4 Childrens Cancer Research Institute, St Anna Childrens Hospital, Vienna, Austria
5 Department of Pathology, University of Lübeck, Germany
Correspondence to:
Correspondence to:
Dr Peter Valent
Department of Internal Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria; peter.valent{at}meduniwien.ac.at
Background: Basophils are highly specialised granulocytes that express a unique profile of antigens and increase in myeloproliferative disorders (MPD). In chronic myeloid leukaemia (CML), basophilia is a diagnostic and prognostic determinant. So far, however, no reliable approach for routine detection and enumeration of bone marrow basophils has become available.
Objective: To detect and enumerate basophils in bone marrow sections in patients with CML and other MPD
Methods: The anti-basophil antibody 2D7 was applied to paraffin embedded bone marrow sections from normal/reactive subjects (n = 31), patients with CML (chronic phase, n = 37; accelerated phase, n = 9), and other MPD (chronic idiopathic myelofibrosis (CIMF), n = 20; polycythaemia vera (PV), n = 20; essential thrombocythaemia (ET), n = 20; indolent systemic mastocytosis (ISM), n = 7).
Results: As assessed by serial section staining, 2D7+ cells were found to co-express myeloperoxidase, histidine decarboxylase, CD9, and CD43, but did not express B cell or T cell restricted antigens. 2D7+ bone marrow cells were found to increase in CML compared with normal/reactive bone marrow and other MPD (median numbers of 2D7+ cells/mm2: CML, 33; normal/reactive bone marrow, 6; CIMF, 10; PV, 6; ET, 5; ISM, 3; p<0.05). The highest basophil counts were recorded in accelerated phase CML (115/mm2).
Conclusions: A novel immunohistochemical procedure has been established for basophil detection in normal bone marrow and MPD. This approach should help in the quantification of bone marrow basophils at diagnosis and during anti-leukaemic treatment.
Abbreviations: CIMF, chronic idiopathic myelofibrosis; CML, chronic myeloid leukaemia; MPD, myeloproliferative disorder; VEGF, vascular endothelial growth factor
Keywords: basophil; chronic myeloid leukaemia; immunohistochemistry; myeloproliferative diseases
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Aichberger, K. J., Mayerhofer, M., Vales, A., Krauth, M.-T., Gleixner, K. V., Bilban, M., Esterbauer, H., Sonneck, K., Florian, S., Derdak, S., Pickl, W. F., Agis, H., Falus, A., Sillaber, C., Valent, P.
(2006). The CML-related oncoprotein BCR/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cells. Blood
108: 3538-3547
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
